期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells 被引量:7
1
作者 Zuo-fu PENG Lin-xiang LAN +4 位作者 Fang ZHAO Jing LI Qiang TAN Han-wei YIN Hui-hui ZENG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2008年第1期16-21,共6页
Human thioredoxin reductase (TrxR) system is associated with cancer cell growth and anti-apoptosis process. Effects of 1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone)ethane (BBSKE),a novel TrxR inhibitor,were investigat... Human thioredoxin reductase (TrxR) system is associated with cancer cell growth and anti-apoptosis process. Effects of 1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone)ethane (BBSKE),a novel TrxR inhibitor,were investigated on human leu-kemia cell lines HL-60 and K562. BBSKE treatment induced cell growth inhibition and apoptosis in both cell lines. Apoptosis induced by BBSKE is through Bcl-2/Bax and caspase-3 pathways. Ehrlich's ascites carcinoma-bearing mice were used to inves-tigate the anti-tumor effect of BBSKE in vivo. Tumor-bearing mice treated with BBSKE showed an increase of life span with a comparable effect to cyclophosphamide (CTX). These results suggest a potential usage of BBSKE as a therapeutic agent against non-solid tumors. 展开更多
关键词 Thioredoxin reductase (TrxR) novel TrxR inhibitor 1 2-[bis(1 2-benzisoselenazolone-3(2H)-ketone)]ethane(BBSKE) APOPTOSIS
下载PDF
BRAF inhibitor:a novel therapy for ameloblastoma in mandible 被引量:3
2
作者 Masanobu Abe Liang Zong +4 位作者 Takahiro Abe Hideyuki Takeshima Jiafu Ji Toshikazu Ushijima Kazuto Hoshi 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2018年第6期677-678,共2页
Ameloblastoma is a benign but locally aggressive odontogenic neoplasm that accounts for 10% of all tumors arising in the mandible and maxilla (1). Eighty percent of ameloblastomas arise in the mandible, and they are u... Ameloblastoma is a benign but locally aggressive odontogenic neoplasm that accounts for 10% of all tumors arising in the mandible and maxilla (1). Eighty percent of ameloblastomas arise in the mandible, and they are usually found in young adults. It frequently recurs if not adequately 展开更多
关键词 BRAF inhibitor:a novel therapy for ameloblastoma in mandible
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部